Healio Rheumatology Current Issue
The following articles appeared in the print edition of Healio Rheumatology.
Table of Contents
- Burnout, Not Otherwise Specified: Defining, Addressing Rheumatologist Burnout
-
- The Cost-Shift Conundrum of Copay Accumulator Programs Michael C. Schweitz, MD
- Rheumatology and Burnout: Causes, Concerns and Hope Leonard H. Calabrese, DO
- FDA Approves Prefilled Autoinjector for Actemra
- FDA Approves Firdapse, First Treatment for Lambert-Eaton Myasthenic Syndrome
- FDA Grants Fast Track Status to Baricitinib Development for SLE
- ACR, National Psoriasis Foundation Stress Treat-to-target, TNF Inhibitors in PsA Guidelines
- How US-Canada-Mexico Trade Deal Could Impact Drug Prices, Research
- Abatacept Improves Patient-reported Outcomes in Psoriatic Arthritis
-
- Blocker Targeting MicroRNA-181a-5p Successfully Treats Knee, Spine OA
- DAPSA-based Remission Better Detects Patient-perceived Remission in PsA
- Knee Pain Lasting 1 Year Predicts Faster Cartilage Loss, Higher OA Risk
- Myocardial Inflammation Frequent in RA, Linked to Disease Activity
- Tanezumab Safe, Effective Against OA
- Supporting Early Career Scientists Aims to Avert Lost Generation of Lupus Researchers
- Gottlieb Decries ‘Anti-competitive Practices’ Delaying Biosimilar Testing
- Outcomes After Switching to Enbrel Biosimilar Influenced by Patient-related Factors
-
- Rheumatologists Should Include Cost, Ability to Pay in RA Treatment Discussions